HSCT is not proven safe or effective for LAL-D by any well-controlled studies, as it is associated with multiorgan failure, sepsis, graft-vs-host disease, and graft failure.2,3 In infants, 100% (10/10) who received HSCT died before 4 years of age; of these, 70% (7/10) died before 9 months of age.4